TY - JOUR T1 - Establishment of a thalassaemia major quality improvement collaborative in Pakistan JF - Archives of Disease in Childhood JO - Arch Dis Child DO - 10.1136/archdischild-2018-315743 SP - archdischild-2018-315743 AU - Zahra Hoodbhoy AU - Lubaina Ehsan AU - Najveen Alvi AU - Fatimah Sajjad AU - Aleezay Asghar AU - Omair Nadeem AU - Asim Qidwai AU - Shabneez Hussain AU - Erum Hasan AU - Sadaf Altaf AU - Salman Kirmani AU - Babar S Hasan Y1 - 2019/02/08 UR - http://adc.bmj.com/content/early/2019/02/08/archdischild-2018-315743.abstract N2 - Objectives The aim of this study was to establish multidisciplinary care for patients with transfusion-dependent thalassaemia (TDT) by creating a TDT quality improvement (QI) collaborative in a resource-constrained setting. This study presents our initial experience of creating this collaborative, the baseline characteristics of the participants, the proposed QI interventions and the outcome metrics of the collaborative.Design and setting TDT QI collaborative is a database comprising patients with TDT from four centres in Karachi, Pakistan. Study variables included symptoms of cardiac or endocrine dysfunction, physical examination including anthropometry and Tanner staging, chelation therapy, results of echocardiography, T2* cardiac MRI (CMR) and serum ferritin. The main outcome of this collaborative was improvement in TDT-related morbidity and mortality. Interventions addressing the key drivers of outcome were designed and implemented.Results At the time of reporting, the total number of patients in this database was 295. Most patients reported cardiac symptoms corresponding to New York Heart Association class 2. Approximately half (52%, n=153) of the patients demonstrated severe myocardial iron overload (T2* <10 ms). Majority of the patients (58%, n=175) were not on adequate chelation therapy. There was no difference in echocardiographic measures of systolic and diastolic left ventricle among the different spectrums of iron overloaded myocardium.Conclusion Using T2* CMR and endocrine testing, we have identified significant burden of iron siderosis in our patients with TDT. Lack of adequate iron load assessment and standardised management was observed. Interventions designed to target these key drivers of outcome are the unique part of this QI-based TDT registry. ER -